Behandlung einer Coviderkrankung
- helga beck am 22.Jan 22, 23:18
- Permalink
17.01.2022
Pressekonferenz FPÖ, Gesundheitssprecher Gerhard Kaniak
Frühzeitige Behandlung von Infizierten: Seit letzten Herbst mehrere zugelassene Medikamente, die verwendet werden könnten. Bis zu 80% vor schweren Verläufen verhindern. Zulassungsstudie eines anderen Medikamentes, bei dem nachgewiesen ist, dass bei frühzeitiger Behandlung innerhalb von 5 Tagen eine Heilung mit 100%iger Verlässlichkeit gezeigt werden konnte. Das heißt, es ist nach 5 Tagen keine Viruslast mehr nachweisbar.
https://www.youtube.com/watch?v=L68Ojw9-8EI
Safety of Ivermectin
Standard doses of ivermectin (0.2 mg/kg x 1?2 days) have a nearly unparalleled safety profile
historically among medicines as evidenced by the following findings:
WHO Guidelines for Scabies: ?the majority of side effects are minor and transient?
Prof Jacques Descotes, Toxicologist, Expert on Safety of Ivermectin: ?severe adverse
events are unequivocally and exceedingly rare?
LiverTox Database: Not considered toxic to the liver
Nephrotox Database- Not considered toxic to the kidney
PneumoTox: Not considered toxic to the lungs
Safety of High Dose Ivermectin
In COVID-19, particularly in regard to the emerging variants of concern, viral loads are higher and
viral replication is thought to be prolonged. Given that ivermectin has demonstrated a strong
dose-response relationship in terms of viral clearance, higher doses have not only been required,
but have demonstrated clinical efficacy. Below are hyperlinked references to numerous studies
demonstrating the wide safety profile of high dose ivermectin in COVID and other diseases
FLCCC Information on Safety of Ivermectin + High Dose Ivermectin (2021-09-21) (covid19criticalcare.com)
Pressekonferenz FPÖ, Gesundheitssprecher Gerhard Kaniak
Frühzeitige Behandlung von Infizierten: Seit letzten Herbst mehrere zugelassene Medikamente, die verwendet werden könnten. Bis zu 80% vor schweren Verläufen verhindern. Zulassungsstudie eines anderen Medikamentes, bei dem nachgewiesen ist, dass bei frühzeitiger Behandlung innerhalb von 5 Tagen eine Heilung mit 100%iger Verlässlichkeit gezeigt werden konnte. Das heißt, es ist nach 5 Tagen keine Viruslast mehr nachweisbar.
https://www.youtube.com/watch?v=L68Ojw9-8EI
Safety of Ivermectin
Standard doses of ivermectin (0.2 mg/kg x 1?2 days) have a nearly unparalleled safety profile
historically among medicines as evidenced by the following findings:
WHO Guidelines for Scabies: ?the majority of side effects are minor and transient?
Prof Jacques Descotes, Toxicologist, Expert on Safety of Ivermectin: ?severe adverse
events are unequivocally and exceedingly rare?
LiverTox Database: Not considered toxic to the liver
Nephrotox Database- Not considered toxic to the kidney
PneumoTox: Not considered toxic to the lungs
Safety of High Dose Ivermectin
In COVID-19, particularly in regard to the emerging variants of concern, viral loads are higher and
viral replication is thought to be prolonged. Given that ivermectin has demonstrated a strong
dose-response relationship in terms of viral clearance, higher doses have not only been required,
but have demonstrated clinical efficacy. Below are hyperlinked references to numerous studies
demonstrating the wide safety profile of high dose ivermectin in COVID and other diseases
FLCCC Information on Safety of Ivermectin + High Dose Ivermectin (2021-09-21) (covid19criticalcare.com)